-
A pilot study of virtual reality for inpatients with opioid use disorder The American Journal on Addictions (IF 3.86) Pub Date : 2024-03-02 Herbert J. Greenwald, Amy Berger, Ronan L. H. Wilson, Daniel J. Greenwald, Eileen Lannon, Phyllis Johnson‐Smith, Brandon G. Bergman, Timothy E. Wilens
Background and ObjectivesWhile inpatient withdrawal management/acute stabilization can improve outcomes for individuals with opioid use disorder (OUD), patients often leave treatment early due to mood, tension, and cravings associated with opioid withdrawal. The aim of this study was to evaluate the feasibility and preliminary effectiveness of a novel virtual reality (VR) based intervention; 3D Therapy
-
Factors associated with transitions in tobacco product use states among young adults aged 18–29 years The American Journal on Addictions (IF 3.86) Pub Date : 2024-02-25 Melissa D. Blank, Nicholas A. Turiano, Bethany C. Bray, Andrea R. Milstred, Margaret Childers, Geri Dino, Katelyn F. Romm
Background and ObjectivesThis study examined young adults’ tobacco use transitions based on their past 30‐day use states, and identified factors associated with their transitions.MethodsParticipants (N = 12377) were young adults aged 18‐29 years at Wave 1 of the Population Assessment of Tobacco and Health (PATH) study. Self‐reported tobacco use states were categorized by the number of past‐month use
-
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case report The American Journal on Addictions (IF 3.86) Pub Date : 2024-02-06 Amber N. Edinoff, David B. Hathaway, David Martinez Garza, Jordan H. Rosen, Joji Suzuki
The decision to initiate pharmacotherapy for alcohol withdrawal is typically based on examining self-reported use of alcohol and symptoms of withdrawal. Phosphatidylethanol (PEth) is a biomarker that could aim in clinical decision-making in withdrawal management.
-
A systematic review and meta-analysis of the relationship between heavy smoking and probability discounting The American Journal on Addictions (IF 3.86) Pub Date : 2024-01-30 Hsien-Jane Chiu, Cheuk-Kwan Sun, Hung-Yu Wang, Han-Yun Chang, Chun-Hsien Kuo, Yu-Ru Sue, Shu-Hsuan Wu, Shih-Yi Tung, Chiao-Yu Lee, Pin-Yang Yeh
Probability discounting (PD), which refers to the process of adjusting the value of future probabilities when making decisions, is a method of measuring impulsive decision-making; however, the relationship between PD and nicotine remains unclear. The current study aimed at investigating the significance of PD in individuals who smoke.
-
Did the 2021 federal change in the practice guidelines for the administration of buprenorphine for treating opioid use disorder increase buprenorphine prescription dispensing in Medicaid population? The American Journal on Addictions (IF 3.86) Pub Date : 2023-12-09 Jingjing Qian, Asmita P. Khatiwada, Xiangzhong Xue
In April 2021, the Department of Health and Human Services released new federal practice guidelines and allowed physicians who wish to treat ≤30 patients with opioid use disorder (OUD) to forego the X-waiver training requirement.
-
Brief report: The influence of childhood trauma on the effects of delta-9-tetrahydrocannabinol in persons with opioid use disorder The American Journal on Addictions (IF 3.86) Pub Date : 2023-12-07 Michael Rogan, Julio C. Nunes, Catherine Z. Xie, Mehmet Sofuoglu, Brian Pittman, Joao P. De Aquino
Childhood trauma (CT) increases addiction vulnerability. We examined CT's impact on delta-9-tetrahydrocannabinol (THC) effects.
-
Gender differences in the prevalence of stimulant misuse in the United States: 2015–2019 The American Journal on Addictions (IF 3.86) Pub Date : 2023-11-04 R. Kathryn McHugh, Francesca M. Korte, Juliette A. Bichon, Roger D. Weiss
The gender gap in prevalence of substance-use disorders has narrowed. However, gender differences in stimulant misuse have not been well-characterized in recent years. The aim of this study was to quantify gender differences in past-year stimulant misuse and stimulant-use disorder, separated by stimulant type (cocaine/crack, prescription stimulants, and methamphetamine). In an exploratory aim, we investigated
-
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine-use disorder The American Journal on Addictions (IF 3.86) Pub Date : 2023-11-04 Meiheng He, Lili Wang, Dong Zhu, Ding Xu, Xiangru Zhu, Suyong Yang
Although both drugs and negative emotions can trigger drug craving or relapse in individuals with methamphetamine-use disorder (MUD), it remains unclear whether individuals with MUD have attentional biases toward both drug and negative emotional cues and whether this bias involves attention orientation or difficulty in attention disengagement. This study aimed to measure different components of attentional
-
Trends in cocaine use among United States females of reproductive age, 2005–2019 The American Journal on Addictions (IF 3.86) Pub Date : 2023-11-04 Madelyn Orndorff, Gayle M. Shipp, Jean M. Kerver, Steven J. Ondersma, Omayma Alshaarawy
The prevalence of cocaine use has increased in the United States, with an estimated 5.5 million people have used it at least once in 2019. We report trends in cocaine use for reproductive age females who participated in the National Survey on Drug Use and Health (NSDUH, 2005–2019).
-
Impulsivity, sex-related alcohol expectancies, alcohol use, and sexual risk-taking among bisexual women The American Journal on Addictions (IF 3.86) Pub Date : 2023-11-04 Amy L. Stamates, Christina T. Schulz, Jodi S. Charvis, Sarah J. Ehlke, Michelle L. Kelley
According to the acquired preparedness model, personality traits, such as impulsivity, may influence the learning process, contributing to heightened expectations surrounding risky behaviors (i.e., alcohol use, sexual risk-taking). As bisexual women demonstrate heightened risk for hazardous alcohol- and sex-related behaviors, the present study examined a sequential pathway, whereby the relation between
-
AJA Annual Meeting 2023 The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-30
Click on the PDF file for live links
-
Call for review papers 2023 The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-30
Click on the PDF file for live links
-
Call for special issue 2023 The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-30
Click on the PDF file for live links
-
2023 Addictions and Their Treatment Course The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-30
Click on the PDF file for live links
-
2023 Advanced Addiction Psychopharmacology Course The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-30
Click on the PDF file for live links
-
Cannabis Use Disorders Performance in Practice The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-30
Click on the PDF file for live links
-
AAAP Membership The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-30
Click on the PDF file for live links
-
Motivational Interviewing Performance in Practice The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-30
Click on the PDF file for live links
-
Psychotherapy Webinar Series The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-30
Click on the PDF file for live links
-
Stimulants Performance in Practice The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-30
Click on the PDF file for live links
-
Exploring the intersection of sexual identity and route of administration in relation to cannabis use among young adult females The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-13 Sarah J. Ehlke, Samantha A. Fitzer, Jennifer L. Shipley, Abby L. Braitman
Rates of cannabis use continue to increase with sexual minority women (SMW) reporting greater use than heterosexual women. Along with these increasing trends, the routes of administration (ROA) for cannabis are evolving. The current study examined associations between cannabis ROA and frequency of use, as well as differences across sexual identity (heterosexual vs. SMW).
-
Marijuana use disorder among adults with functional disabilities—A US population-based cross-sectional study The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-11 Zhigang Xie, Sericea Stallings-Smith, Nichole Stetten, Hanadi Y. Hamadi, Nicole M. Marlow
Recent studies suggest a growing trend in marijuana use, compared to a stable prevalence of marijuana use disorder among US adults over the first 15 years of the 21st century. This study investigated the recent patterns of marijuana use disorder among people with disabilities (PWD).
-
Brief report: Characterization of electronic cigarette use among patients of a comprehensive cancer center The American Journal on Addictions (IF 3.86) Pub Date : 2023-10-08 Jason D. Robinson, George Kypriotakis, Maher Karam-Hage, Yong Cui, Diane Beneventi, Janice A. Blalock, Jennifer A. Minnix, Paul M. Cinciripini
We provide an initial characterization of e-cigarette use among adult cancer patients.
-
Personality predicting relapse: A facet analysis of the NEO PI-R The American Journal on Addictions (IF 3.86) Pub Date : 2023-09-04 Zalman Faltushanskiy, Amy A. Herrold, Jasper Werby, Eliza M. Betteridge, Daniel Angres
Revised NEO Personality Inventory (NEO PI-R) domains are associated with substance use disorders (SUD), including potential for relapse. However, individual facets of the NEO PI-R domains have not been rigorously analyzed. This paper assesses NEO PI-R individual facets among participants with SUD and their value in predicting relapse.
-
AJA Annual Meeting 2023 The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-24
Click on the PDF file for live links
-
Call for review papers 2023 The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-24
Click on the PDF file for live links
-
Call for special issue 2023 The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-24
Click on the PDF file for live links
-
Psychotherapy Webinar Series AJA The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-24
Click on the PDF file for live links
-
Motivational Interviewing PIP The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-24
Click on the PDF file for live links
-
Cannabis Use PIP Ad The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-24
Click on the PDF file for live links
-
Become a AAAP Member The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-24
Click on the PDF file for live links
-
2023 Advanced Addiction Psychopharmacology Course The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-24
Click on the PDF file for live links
-
2023 Addictions and Their Treatment Course The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-24
Click on the PDF file for live links
-
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-15 Ethan Sahker, George Pro, Hemant Poudyal, Toshi A. Furukawa
Only 10% of Americans with substance use disorders (SUDs) receive treatment with insufficient treatment access and screening practices proposed and potential contributing factors.
-
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-15 Margaret Paschen-Wolff, Shelly F. Greenfield, R. Kathryn McHugh, Kathleen Burlew, Martina Pavlicova, Tse-Hwei Choo, Celestina Barbosa-Leiker, Lesia M. Ruglass, Sarah Mennenga, John Rotrosen, Edward V. Nunes, Aimee N. C. Campbell
Limited research has explored sex differences in opioid use disorder medication (MOUD) treatment outcomes. The purpose of this study was to examine MOUD initiation onto buprenorphine-naloxone (BUP-NX) versus extended-release naltrexone (XR-NTX) by sex, and sex differences in clinical and psychosocial outcomes.
-
Are DEA-waivered buprenorphine prescribers colocated with behavioral health clinicians? The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-09 Lisa de Saxe Zerden, Connor Sullivan, Evan Galloway, Erica L. Richman, Maria G. Gaiser, Brianna Lombardi
Medication for opioid use disorder (MOUD) in primary care includes a combination of medication, behavioral therapy, and/or other psychosocial services. This study assessed rates of colocation between waivered prescribers and behavioral health clinicians across the United States to understand if rates varied by provider type and geographic indicators.
-
Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-08 Michael Kidorf, Jessica Peirce, Robert K. Brooner, Haijuan Yan, Carl Latkin
People receiving agonist treatment for opioid use disorder often have family or friends who do not use illicit substances and could be mobilized to support recovery efforts. The present study evaluates the feasibility and preliminary efficacy of a community support intervention (CSI) designed to increase drug-free social support and expand drug-free network support.
-
Medication treatment for alcohol use disorder in special populations The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-08 Aniket Malhotra, Karen Drexler, Michael Hsu, Yi-lang Tang
Alcohol use disorder (AUD) is a significant public health concern, with underutilized effective treatments, particularly in special populations. This article summarizes the current evidence and guidelines for treating AUD in special populations.
-
Addiction specialists' attitudes toward psychedelics: A National Survey The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-07 Amanda Kim, Joji Suzuki
In recent years, there has been accelerating scientific and public interest in the use of psychedelics to treat mental health disorders. Our study's objective was to assess the attitudes of addiction specialists regarding therapeutic psychedelics.
-
Daily cannabis use may cause cannabis-induced hyperalgesia The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-07 Yanli Zhang-James, Evelyn Wyon, Dennis Grapsas, Brian Johnson
Public opinion about cannabis as a medical treatment is generally favorable. As many as 35% of primary care patients report medical use of cannabis, most commonly for pain treatment. We designed a way to test whether cannabis helps chronic pain.
-
Years of life lost to drug overdose in the Latinx community during the most recent wave of overdose deaths The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-06 Rebecca A. Harris, David S. Mandell
This study estimated years of life lost (YLL) among US Latinx individuals during the most recent wave of drug overdose deaths.
-
Gambling, tobacco use, and health among individuals in substance use disorder treatment The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-06 Anna Pagano, Thao Le, Timothy Fong, Rory Reid, Kevin Delucchi, Joseph Guydish
Gambling is highly comorbid with disordered use of tobacco and other drugs, and may increase relapse risk among substance use disorder (SUD) patients. We investigated associations between gambling and tobacco use behaviors among SUD patients to inform clinical care.
-
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID-19 pandemic The American Journal on Addictions (IF 3.86) Pub Date : 2023-08-06 Joseph A. Rosansky, Mark Albanese, Joshua Phillips, Zev Schuman-Olivier
We explored potential challenges to accessing office-based opioid treatment (OBOT) with buprenorphine during the COVID-19 pandemic.
-
Call for review papers 2023 The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-29
Click on the PDF file for live links
-
Call for special issue 2023 The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-29
Click on the PDF file for live links
-
AJA Psychedelics ad The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-29
Click on the PDF file for live links
-
AATT & AAP The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-29
Click on the PDF file for live links
-
Travel Award AJA The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-29
Click on the PDF file for live links
-
Psychotherapy Webinar Series AJA The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-29
Click on the PDF file for live links
-
Cannabis Use PIP Ad The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-29
Click on the PDF file for live links
-
Become a AAAP Member The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-29
Click on the PDF file for live links
-
Social vulnerability predictors of drug poisoning mortality: A machine learning analysis in the United States The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-21 Moosa Tatar, Mohammad R. Faraji, Katherine Keyes, Fernando A. Wilson, Mohammad S. Jalali
Drug poisoning is a leading cause of unintentional deaths in the United States. Despite the growing literature, there are a few recent analyses of a wide range of community-level social vulnerability features contributing to drug poisoning mortality. Current studies on this topic face three limitations: often studying a limited subset of vulnerability features, focusing on small sample sizes, or solely
-
Promoter region variant C-824T in the TH gene modulates the subjective effects of cocaine The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-20 Peter K. Bolin, Ellen M. Nielsen, David A. Nielsen, Richard De La Garza
This study examined how a promoter variant of TH (rs10770141) affects subjective effects of cocaine in 65 nontreatment-seeking individuals with cocaine dependence.
-
Survey of stigma across healthcare workers in an urban, academic medical center regarding perinatal patients using opioids The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-20 Alexis Braverman, Tiffany Lin, Sarah Messmer, Kathy Wollner, Renee Taylor, Adrienne A. Williams, Quetzal A. Class
To examine healthcare workers' attitudes towards pregnant woman using opioids across provider type, specialty, and years of service.
-
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-17 Heba Ragheb, Shireen Ahmad, Sarah Uddin, Bernard Le Foll, Ahmed N. Hassan
Research on substance use disorder (SUD) among Muslims in the United States (US) is limited. There are several unique factors, including denial and stigma, that make this population at risk of SUD. This study explored the prevalence, treatment utilization, and impact of SUD among Muslims in the US compared with a matched control group from general respondents.
-
A pilot test of Written Exposure Therapy for PTSD in residential substance use treatment The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-17 Rebecca L. Schacht, Kevin R. Wenzel, Laurel E. Meyer, Meghan Mette, Kamala Mallik-Kane, Aline Rabalais, Samantha K. Berg, Marc Fishman
Posttraumatic stress disorder (PTSD) is highly comorbid with substance use disorders (SUD) and can impede SUD recovery. Residential SUD treatment is a crucial opportunity to address PTSD. However, PTSD treatment is lacking in residential SUD care.
-
Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-12 Hamzah Bakouni, Christina McAnulty, Ovidiu Tatar, M. Eugenia Socias, Bernard Le Foll, Ron Lim, Keith Ahamad, Didier Jutras-Aswad
Buprenorphine/naloxone (BUP-NX) and methadone are used to treat opioid use disorder (OUD), yet there is insufficient evidence on the impact of doses on interventions' effectiveness and safety when treating OUD attributable to other opioids than heroin.
-
Medical marijuana access and prolonged opioid use among adolescents and young adults The American Journal on Addictions (IF 3.86) Pub Date : 2023-06-08 Kyungha Kim, Rosalie L. Pacula, Andrew W. Dick, Bradley D. Stein, Benjamin G. Druss, Edeanya Agbese, Austin C. Cohrs, Douglas L. Leslie
Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults.
-
The impact of body image dissatisfaction on psychological distress and health-related quality of life among patients in methadone treatment The American Journal on Addictions (IF 3.86) Pub Date : 2023-05-15 Meagan M. Carr, Zachary L. Mannes, Lindsay M. S. Oberleitner, David E. Oberleitner, Mark Beitel, Marina G. Gazzola, Lynn M. Madden, Xiaoying Zheng, Declan T. Barry
Minimal research has examined body image dissatisfaction (BID) among patients receiving methadone maintenance treatment (MMT). We tested associations between BID and MMT quality indicators (psychological distress, mental and physical health-related quality of life [HRQoL]) and whether these associations varied by gender.
-
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment-seeking cohort The American Journal on Addictions (IF 3.86) Pub Date : 2023-05-02 Nicholas L. Bormann, Andrea N. Weber, Stephan Arndt, Alison Lynch
Comorbid substance use can negatively impact multiple aspects of treatment for patients with an opioid use disorder (OUD). We investigated if treatment for OUD led to improvements in patients' recovery capital (RC) overtime, and whether there were associated changes in co-occurring alcohol use.